BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Genzyme, Valeant Pharmaceuticals sales and marketing update

Genzyme granted Valeant's Biovail Laboratories International SRL subsidiary rights to market Cholestagel colesevalem in Canada. The non-absorbed bile acid...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >